Jennifer L. Beaumont	Received grants from GlaxoSmithKline for the conduct of the study and personal fees from GlaxoSmithKline, Gilead, and Ipsen outside the submitted work.
John M. Salsman	Reports other (support for manuscript writing) from GlaxoSmithKline during the conduct of the study.
Jose Diaz	Was employed by GlaxoSmithKline and Novartis, and owned stock in GlaxoSmithKline.
Keith Deen	Was employed by GlaxoSmithKline and owned stock in GlaxoSmithKline.
Lauren McCann	Was employed by GlaxoSmithKline and owned stock in GlaxoSmithKline.
Thomas Powles	Reports personal fees from Roche, Novartis and Pfizer outside the submitted work.
Michelle D. Hackshaw	Reports employment (former) by and stock ownership in GlaxoSmithKline.
Robert J. Motzer	Reports grants from GlaxoSmithKline during the conduct of the study; grants and personal fees from Novartis and Pfizer outside the submitted work.
David Cella	Reports personal fees from GlaxoSmithKline outside the submitted work.